HEADER TRANSFERASE 06-NOV-03 1RE8 TITLE CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE TITLE 2 COMPLEXED WITH BALANOL ANALOG 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC COMPND 3 SUBUNIT; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PKA C-ALPHA; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSETB KEYWDS PROTEIN KINASE, NATURAL PRODUCT INHIBITOR, LIGAND BINDING, KEYWDS 2 SPECIFICITY DETERMINANTS, CONFORMATIONAL MALLEABILITY, KEYWDS 3 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.AKAMINE,MADHUSUDAN,L.L.BRUNTON,H.D.OU,J.M.CANAVES, AUTHOR 2 N.H.XUONG,S.S.TAYLOR REVDAT 2 24-FEB-09 1RE8 1 VERSN REVDAT 1 24-FEB-04 1RE8 0 JRNL AUTH P.AKAMINE,MADHUSUDAN,L.L.BRUNTON,H.D.OU, JRNL AUTH 2 J.M.CANAVES,N.H.XUONG,S.S.TAYLOR JRNL TITL BALANOL ANALOGUES PROBE SPECIFICITY DETERMINANTS JRNL TITL 2 AND THE CONFORMATIONAL MALLEABILITY OF THE CYCLIC JRNL TITL 3 3',5'-ADENOSINE MONOPHOSPHATE-DEPENDENT PROTEIN JRNL TITL 4 KINASE CATALYTIC SUBUNIT JRNL REF BIOCHEMISTRY V. 43 85 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 14705934 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.NARAYANA,T.C.DILLER,K.KOIDE,M.E.BUNNAGE, REMARK 1 AUTH 2 K.C.NICOLAOU,L.L.BRUNTON,N.-H.XUONG,L.F.TEN EYCK, REMARK 1 AUTH 3 S.S.TAYLOR REMARK 1 TITL CRYSTAL STRUCTURE OF THE POTENT NATURAL PRODUCT REMARK 1 TITL 2 INHIBITOR BALANOL IN COMPLEX WITH THE CATALYTIC REMARK 1 TITL 3 SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE REMARK 1 REF BIOCHEMISTRY V. 38 2367 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI9820659 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 20722 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2733 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 275 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 2.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RE8 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-DEC-03. REMARK 100 THE RCSB ID CODE IS RCSB020679. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-98 REMARK 200 TEMPERATURE (KELVIN) : 96 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20722 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 0.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 1BX6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MPD, BICINE, MEGA-9, PH 8, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.90000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.80000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.90000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.80000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 LYS A 21 CG CD CE NZ REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 GLU A 86 CG CD OE1 OE2 REMARK 470 LYS A 105 CG CD CE NZ REMARK 470 GLN A 176 CG CD OE1 NE2 REMARK 470 GLN A 242 CG CD OE1 NE2 REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 295 CG CD CE NZ REMARK 470 GLU A 311 CG CD OE1 OE2 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 ARG A 336 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 345 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 62 NE2 HIS A 62 CD2 -0.077 REMARK 500 HIS A 68 NE2 HIS A 68 CD2 -0.068 REMARK 500 HIS A 87 NE2 HIS A 87 CD2 -0.072 REMARK 500 HIS A 131 NE2 HIS A 131 CD2 -0.066 REMARK 500 HIS A 142 NE2 HIS A 142 CD2 -0.067 REMARK 500 HIS A 158 NE2 HIS A 158 CD2 -0.068 REMARK 500 HIS A 260 NE2 HIS A 260 CD2 -0.072 REMARK 500 HIS A 294 NE2 HIS A 294 CD2 -0.074 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 30 CD1 - CG - CD2 ANGL. DEV. = 6.3 DEGREES REMARK 500 TRP A 30 CE2 - CD2 - CG ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG A 144 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 144 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 TRP A 196 CD1 - CG - CD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 TRP A 196 CE2 - CD2 - CG ANGL. DEV. = -6.5 DEGREES REMARK 500 TRP A 196 CG - CD2 - CE3 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP A 221 CD1 - CG - CD2 ANGL. DEV. = 6.6 DEGREES REMARK 500 TRP A 221 CE2 - CD2 - CG ANGL. DEV. = -6.5 DEGREES REMARK 500 TRP A 221 CG - CD2 - CE3 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP A 222 CD1 - CG - CD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 TRP A 222 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 LEU A 277 CA - CB - CG ANGL. DEV. = 18.1 DEGREES REMARK 500 TRP A 296 CD1 - CG - CD2 ANGL. DEV. = 6.4 DEGREES REMARK 500 TRP A 296 CE2 - CD2 - CG ANGL. DEV. = -6.3 DEGREES REMARK 500 TRP A 302 CD1 - CG - CD2 ANGL. DEV. = 6.7 DEGREES REMARK 500 TRP A 302 CE2 - CD2 - CG ANGL. DEV. = -6.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 82 67.20 -105.22 REMARK 500 LYS A 83 97.45 -18.14 REMARK 500 GLN A 84 26.35 -149.86 REMARK 500 ASN A 99 108.56 -167.11 REMARK 500 ARG A 165 32.79 -92.09 REMARK 500 ASP A 166 52.57 -149.67 REMARK 500 THR A 183 -163.36 -126.74 REMARK 500 ASN A 216 -160.97 -128.33 REMARK 500 LEU A 273 39.57 -96.77 REMARK 500 LYS A 319 -113.32 -92.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 426 DISTANCE = 5.05 ANGSTROMS REMARK 525 HOH A 535 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH A 545 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A 560 DISTANCE = 5.61 ANGSTROMS REMARK 525 HOH A 561 DISTANCE = 6.85 ANGSTROMS REMARK 525 HOH A 577 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 600 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH A 612 DISTANCE = 5.28 ANGSTROMS REMARK 525 HOH A 631 DISTANCE = 5.78 ANGSTROMS REMARK 525 HOH A 641 DISTANCE = 5.14 ANGSTROMS REMARK 525 HOH A 642 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 646 DISTANCE = 6.33 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OCT A 555 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BD2 A 351 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OCT A 555 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BX6 RELATED DB: PDB REMARK 900 PKA C SUBUNIT COMPLEXED WITH BALANOL REMARK 900 RELATED ID: 1ATP RELATED DB: PDB REMARK 900 PKA C SUBUNIT COMPLEXED WITH ATP AND INHIBITOR PEPTIDE DBREF 1RE8 A 1 350 UNP P05132 KAPCA_MOUSE 1 350 SEQADV 1RE8 TPO A 197 UNP P05132 THR 197 MODIFIED RESIDUE SEQADV 1RE8 SEP A 338 UNP P05132 SER 338 MODIFIED RESIDUE SEQRES 1 A 350 GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN GLU SEQRES 2 A 350 SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP PHE SEQRES 3 A 350 LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA GLN SEQRES 4 A 350 LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR GLY SEQRES 5 A 350 SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SER SEQRES 6 A 350 GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN LYS SEQRES 7 A 350 VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN GLU SEQRES 8 A 350 LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU VAL SEQRES 9 A 350 LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU TYR SEQRES 10 A 350 MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SER SEQRES 11 A 350 HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS ALA SEQRES 12 A 350 ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU TYR SEQRES 13 A 350 LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS PRO SEQRES 14 A 350 GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN VAL SEQRES 15 A 350 THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG THR SEQRES 16 A 350 TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO GLU SEQRES 17 A 350 ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP TRP SEQRES 18 A 350 TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA GLY SEQRES 19 A 350 TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE TYR SEQRES 20 A 350 GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER HIS SEQRES 21 A 350 PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU LEU SEQRES 22 A 350 GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS ASN SEQRES 23 A 350 GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA THR SEQRES 24 A 350 THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU ALA SEQRES 25 A 350 PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SER SEQRES 26 A 350 ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEP SEQRES 27 A 350 ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE MODRES 1RE8 TPO A 197 THR PHOSPHOTHREONINE MODRES 1RE8 SEP A 338 SER PHOSPHOSERINE HET TPO A 197 11 HET SEP A 338 10 HET BD2 A 351 35 HET OCT A 555 7 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM BD2 3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN-4-YL 4-(2- HETNAM 2 BD2 HYDROXYBENZOYL)BENZOATE HETNAM OCT N-OCTANE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE HETSYN BD2 BALANOL ANALOG 2 FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 BD2 C27 H26 N2 O6 FORMUL 3 OCT C8 H18 FORMUL 4 HOH *275(H2 O) HELIX 1 1 GLN A 12 THR A 32 1 21 HELIX 2 2 GLN A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 VAL A 98 1 15 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 ASP A 184 ALA A 188 5 5 HELIX 9 9 THR A 201 LEU A 205 5 5 HELIX 10 10 ALA A 206 LEU A 211 1 6 HELIX 11 11 LYS A 217 GLY A 234 1 18 HELIX 12 12 GLN A 242 SER A 252 1 11 HELIX 13 13 SER A 262 LEU A 273 1 12 HELIX 14 14 VAL A 288 ASN A 293 1 6 HELIX 15 15 HIS A 294 ALA A 298 5 5 HELIX 16 16 ASP A 301 GLN A 307 1 7 SHEET 1 A 5 PHE A 43 GLY A 52 0 SHEET 2 A 5 GLY A 55 HIS A 62 -1 O LEU A 59 N LYS A 47 SHEET 3 A 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 A 5 ASN A 115 GLU A 121 -1 O MET A 118 N LYS A 72 SHEET 5 A 5 LEU A 106 LYS A 111 -1 N PHE A 108 O VAL A 119 SHEET 1 B 2 LEU A 162 ILE A 163 0 SHEET 2 B 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 C 2 LEU A 172 ILE A 174 0 SHEET 2 C 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C TRP A 196 N TPO A 197 1555 1555 1.34 LINK C TPO A 197 N LEU A 198 1555 1555 1.34 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 SITE 1 AC1 23 GLY A 50 THR A 51 GLY A 52 SER A 53 SITE 2 AC1 23 PHE A 54 GLY A 55 VAL A 57 ALA A 70 SITE 3 AC1 23 LYS A 72 LEU A 74 GLU A 91 GLU A 121 SITE 4 AC1 23 TYR A 122 VAL A 123 GLU A 127 GLU A 170 SITE 5 AC1 23 ASN A 171 LEU A 173 THR A 183 ASP A 184 SITE 6 AC1 23 GLY A 186 HOH A 352 HOH A 369 SITE 1 AC2 5 LEU A 19 ALA A 20 GLU A 24 SER A 159 SITE 2 AC2 5 HOH A 558 CRYST1 51.800 71.600 97.700 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019305 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013966 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010235 0.00000 MASTER 383 0 4 16 9 0 8 6 0 0 0 27 END